📰 Systemic Sclerosis News
Page 7 - Systemic Sclerosis News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Systemic Sclerosis. Real-time updates on events, politics, business and more.
November 13, 2022
/PRNewswire/ -- Chemomab Therapeutics, Ltd. (Nasdaq: CMMB), a clinical-stage biotechnology company focused on the discovery and development of innovative...
November 9, 2022
BIOSENIC Euronext Brussels and Paris: BIOS), the company specialized in serious autoimmune inflammatory diseases and cell repair, today announces an update on its systemic autoimmune disease... | November 9, 2022
November 8, 2022
REGULATED INFORMATION The autoimmune disease platform has completed a successful phase IIb trial targeting cGVHD (chronic Graft vs Host Disease), with a...
November 8, 2022
Strongly supports therapeutic potential in one of CAN10's lead indications LUND, Sweden, Nov. 8, 2022 /PRNewswire/ -- Cantargia (Cantargia AB) (Nasdaq Stockholm: CANTA) today reported new
November 8, 2022
/PRNewswire/ -- Cantargia (Cantargia AB) (Nasdaq Stockholm: CANTA) today reported new preclinical data demonstrating positive effects of the IL1RAP-binding...
November 8, 2022
Company Also Delivers Growing Cash Flow from Operations NASHVILLE, Tenn., Nov. 8, 2022 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. , a specialty pharmaceutical company, announced today that... | November 8, 2022
November 8, 2022
(Nasdaq Stockholm: CANTA) today reported new preclinical data demonstrating positive effects of the...
November 8, 2022
/PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, announced today that its product portfolio of FDA-approved...
November 2, 2022
NASHVILLE, Tenn., Nov. 1, 2022 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), the largest, public biopharmaceutical company founded and headquartered in Tennessee, announced today that it has moved its headquarters
November 1, 2022
/PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), the largest, public biopharmaceutical company founded and headquartered in Tennessee, announced...